ATH-407

N/A

Report date: 2024/11/13 15:02:05
NME

Base Information

Drug NameATH-407
Drug Alias NameATH-407
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear receptor subfamily 4 group A member 2 agonists
TargetsNuclear receptor subfamily 4 group A member 2
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNurrOn Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesNurrOn Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A